Division of Gastroenterology and Hepatology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, U.S.A.
Inflamm Bowel Dis. 1996 Spring;2(1):48-60.
: Genetic influence in the susceptibility to inflammatory bowel disease (IBD) is suggested by racial, ethnic, and familial aggregation of disease. Increased concordance for IBD in monozygotic compared with dizygotic twins suggests that genetic rather than environmental factors are primarily responsible for the familial aggregation. A dramatically increased risk for IBD in siblings compared with spouses of affected individuals and many instances of temporal and geographic separation of disease onset in affected relatives also suggest that the familial aggregation of IBD is primarily due to genetic factors. The complex genetics of IBD involves incomplete penetrance and probably involves oligogenic inheritance and genetic heterogeneity. Identification of subclinical markers and markers of genetic heterogeneity in IBD to address the likely problems of incomplete penetrance and genetic heterogeneity would greatly simplify the task of finding IBD susceptibility loci in well-designed genetic marker association and linkage studies. Potential subclinical markers and markers of genetic heterogeneity in IBD are reviewed, as are candidate-gene studies. In addition to candidate-gene studies, future studies should include whole genome screening by using polymorphic genetic markers throughout the genome systematically to map IBD-susceptibility loci. Currently available molecular biologic technology with highly informative polymorphic genetic markers should permit successful identification of IBD-susceptibility genes.
遗传因素在炎症性肠病 (IBD) 的易感性中起作用,这可以从疾病的种族、民族和家族聚集现象中得到证明。同卵双胞胎比异卵双胞胎的 IBD 一致性更高,这表明遗传因素而非环境因素是导致家族聚集的主要原因。与受影响个体的配偶相比,IBD 患者的兄弟姐妹患病风险显著增加,并且许多受影响亲属的疾病发作时间和地点也存在分离,这也表明 IBD 的家族聚集主要是由于遗传因素。IBD 的复杂遗传涉及不完全外显率,可能涉及寡基因遗传和遗传异质性。鉴定 IBD 中的亚临床标志物和遗传异质性标志物,以解决不完全外显率和遗传异质性的问题,将极大地简化在精心设计的遗传标记关联和连锁研究中寻找 IBD 易感基因座的任务。本文回顾了 IBD 中的潜在亚临床标志物和遗传异质性标志物,以及候选基因研究。除了候选基因研究外,未来的研究还应包括通过在整个基因组中系统地使用多态遗传标记进行全基因组筛查,以绘制 IBD 易感性基因座图。目前可用的分子生物学技术具有高度信息多态遗传标记,应能成功鉴定 IBD 易感基因。